Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Xenon Pharmaceuticals Inc., 3 years.
Xenon Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +9,318 | $7.69 | $71,655 |
| Jun 1, 2023 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −1,860 | $38.53 | $71,666 |
| Jun 1, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −7,458 | $38.97 | $290,638 |
| Jun 1, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +45,000 | $17.76 | $799,200 |
| Jun 1, 2023 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −20,745 | $38.53 | $799,305 |
| Jun 1, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −24,255 | $38.78 | $940,609 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −12,000 | $38.53 | $462,360 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +29,835 | $9.85 | $293,875 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −6,165 | $38.37 | $236,551 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −23,670 | $38.81 | $918,633 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +50,000 | $17.76 | $888,000 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −23,144 | $38.37 | $888,035 |
| May 31, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −26,856 | $38.69 | $1,039,059 |
| May 30, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −18,006 | $38.63 | $695,572 |
| May 30, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −19,000 | $39.90 | $758,100 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.